Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Vaxart, Inc. | vxrt20201211_10k.htm |
| EX-32.1 - EXHIBIT 32.1 - Vaxart, Inc. | ex_217182.htm |
| EX-31.1 - EXHIBIT 31.1 - Vaxart, Inc. | ex_217181.htm |
| EX-23.2 - EXHIBIT 23.2 - Vaxart, Inc. | ex_217180.htm |
| EX-21.1 - EXHIBIT 21.1 - Vaxart, Inc. | ex_217178.htm |
| EX-10.40 - EXHIBIT 10.40 - Vaxart, Inc. | ex_224964.htm |
| EX-4.11 - EXHIBIT 4.11 - Vaxart, Inc. | ex_227470.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements on Form S-3 (No. 333-239751, 333-228910) and Form S-8 (No. 333-239727, 333-231013, 333-225475, 333-215141, 333-143238) of Vaxart, Inc. of our reports dated February 25, 2021 relating to the consolidated financial statements and the effectiveness of Vaxart, Inc.’s internal control over financial reporting, which reports appear in this Annual Report on Form 10-K.
/s/ OUM & Co. LLP
San Francisco, California
February 25, 2021